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The fucosylated ABH antigens, which constitute the molecular basis for the ABO blood group system, are also
expressed in salivary secretions and gastrointestinal epithelia in individuals of positive secretor status; however, the
biological function of the ABO blood group system is unknown. Gastric mucosa biopsies of 41 Rhesus monkeys
originating from Southern Asia were analyzed by immunohistochemistry. A majority of these animals were found to be
of blood group B and weak-secretor phenotype (i.e., expressing both Lewis a and Lewis b antigens), which are also
common in South Asian human populations. A selected group of ten monkeys was inoculated with Helicobacter pylori
and studied for changes in gastric mucosal glycosylation during a 10-month period. We observed a loss in mucosal
fucosylation and concurrent induction and time-dependent dynamics in gastric mucosal sialylation (carbohydrate
marker of inflammation), which affect H. pylori adhesion targets and thus modulate host–bacterial interactions. Of
particular relevance, gastric mucosal density of H. pylori, gastritis, and sialylation were all higher in secretor individuals
compared to weak-secretors, the latter being apparently ‘‘protected.’’ These results demonstrate that the secretor
status plays an intrinsic role in resistance to H. pylori infection and suggest that the fucosylated secretor ABH antigens
constitute interactive members of the human and primate mucosal innate immune system.
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Introduction
In turbulent systems such as the oro-gastro-intestinal tract,
adaptation to local niches requires microbial adherence
properties to match host receptors and thereby stabilize
microbial colonization or infection. H. pylori achieved this
goal by developing the BabA and SabA adhesins, which bind
to the host fucosylated blood group (bg) ABO antigens
(denoted the ABH antigens) and sialylated Lewis antigens,
respectively [1–5]. These adhesins are relevant to H. pylori
pathogenicity since BabA-positive strains are frequently
present in both peptic ulceration and gastric cancer [5–8].
H. pylori infection and associated gastritis induce expression
of mucosal sialylated receptors for the SabA adhesin that also
attract peripheral neutrophils to local areas of inﬂammation
[2,9]. In turn, H. pylori SabA adhesin acts as a ‘‘selectin-mimic’’
in mediating binding to both sialylated epithelium and to
neutrophils [2,10].
The A, B, and H antigens are complex fucosylated
carbohydrates expressed on erythrocytes of all individuals
of blood group A, B, or O, respectively. The common
denominator is the Fuca1.2-glycan presented by all three
ABH antigens, because the bone marrow (from where the
erythrocytes originate) express the common H-(fucosyl)trans-
ferase. Lack of fucosylated ABH antigens on erythrocytes in
circulation (Bombay phenotype) is exceedingly rare. The
ABH antigens are also expressed along the oro-gastro-
intestinal (GI) mucosal lining in individuals of ‘‘positive
secretor status’’ (secretor phenotype, Se) [11,12]. This is
because Se individuals express the Secretor-(fucosyl)transfer-
ase, which is the enzyme that produces the Fuca1.2-glycan
structure, the hallmark of ABH antigens in saliva, and
gastrointestinal mucus secretions and epithelium (see Figure
1A for bg antigens). Due to the mucosal secretor-transferase,
gastrointestinal epithelia of secretors express blood group O
antigens [Lewis b (Le
b) and H antigens], which can be
extended by a GalNAc- or Gal-residue into bg A or B
antigens, respectively [12] (Figure 1). In contrast, individuals
of non-secretor phenotype, Se
0, lack the secretor-transferase
altogether, and make the shorter Lewis a antigen (Le
a) [13]
(Figure 1). A third and most recently described human
secretor phenotype, the weak-secretor phenotype, Se
w,i s
characterized by expression of both Le
a and Le
b antigens. The
composite of Le
a and Le
b antigens is the consequence of a
weak (mutated) form of the secretor transferase [11] (Figure
1B and Figure 1C).
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teins carrying multitudes of carbohydrate structures covers
the mucosal surfaces. This glyco-mucus layer exhibits rapid
turnover and is shed into the GI tract lumen together with
scavenged and aggregated secretions, desquamated cells, and
microorganisms. Mucins from both humans and Rhesus
monkeys efﬁciently bind H. pylori via fucosylated carbohy-
drates [14,15]. Thus, fucosylated host secretions such as
mucins, saliva, and milk, inhibit adherence of H. pylori and
other microbial pathogens to the mucosal cell surfaces [16–
18].
A majority of Caucasians (80%) are secretors, whereas 20%
of them are non-secretors, and weak-secretor individuals are
rare or not yet discovered. In contrast, weak-secretor
individuals are common among Chinese, Japanese, Polyne-
sians, Australian aborigines, and African-Americans [11]. The
skewed prevalence in secretor phenotypes suggests selection
in response to speciﬁc types of infections or other environ-
mental conditions. Indeed, Se
0 individuals are more at risk
for urinary tract infections [19,20]; Se
0 subjects also express
higher inﬂammatory reactivity and sialylated host antigens to
H. pylori infection, which may explain the higher prevalence
of peptic ulcer disease observed in those subjects [21–23]. In
contrast, Se
0 individuals are less likely to develop Norwalk
virus–induced acute gastroenteritis due to the lack of
mucosal Se-dependent ABH antigens that mediate mucosal
adherence of virus particles in Se subjects [24].
Here, the dynamics of mucosal responses to H. pylori
infection was studied in Rhesus monkeys because this animal
is subject to natural H. pylori infection and exhibits human-
like patterns of gastric glycosylation [15,25–27]. Furthermore,
the complete description of the macaque genome is available
for this important primate model [28]. After determining the
ABO blood groups and secretor phenotypes of 41 Rhesus
monkeys, we inoculated virulent H. pylori strains to repre-
sentative secretor groups. During the persistent H. pylori
infection that ensued, gastric mucosal fucosylation transi-
ently decreased and sialylation reciprocally increased. In vivo
H. pylori density, inﬂammation, and in vitro adherence of H.
pylori to sialylated antigens were all lower among weak-
secretors (the common Rhesus monkey phenotype) compared
to regular secretors.
We propose that mucosal glycosylation on GI cell surfaces
and secretions as determined by secretor status together
inﬂuence the course of H. pylori infection as part of the
primate innate immunity.
Results
Rhesus Monkey ABO Blood Groups and Secretor
Phenotypes
Immunostaining of gastric biopsies from 41 Rhesus
monkeys without H. pylori infection demonstrated that 28
animals (68%) were of bg B and 13 (32%) were of bg AB.
Thus, mucosal bg B antigen was expressed in all 41 monkeys.
The positive immunostaining of bg B and A antigens in the
gastric epithelium also demonstrates that all animals were
secretors (Se) of ABH-antigens and, hence, that non-secretors
(Se
0 that lack ABH antigens in the GI mucosal lining) were
not represented in this large group of monkeys (Figure 1). In
addition, 34/41 (83%) animals expressed both Le
a and Le
b,a n
antigen combination that, in humans, is regarded as the
characteristics of the weak-secretor phenotype (Se
w). Only
seven monkeys did not express mucosal Le
a and they were
identiﬁed as regular Se. Thus, Se
w status with the weak form
of secretor transferase appears to be the predominant
secretor phenotype in the Rhesus monkey.
Secretor Phenotype Affects H. pylori Infection Density and
Gastritis
A total of ten animals, 3/7 Se (bg B) and 7/34 Se
w (bg B, Le
aþ
Le
bþ) animals, were selected for H. pylori inoculation experi-
ments, and two virulent CagA and VacA positive H. pylori
strains became predominant in most animals after a few
months [29]. We determined that these two strains could bind
both ABH and sLe
a/x antigens (see Materials and Methods).
Persistent high-grade infection was observed in 9/10 monkeys
and only animal 86D02 (Se
w) demonstrated low-grade
infection (H. pylori score of 1, gastritis score ranging from 1
to 2, but negative cultures, Table S1).
H. pylori infection and associated gastritis developed
similarly in the antrum (Figure 2A and 2C) and in the corpus
(Figure S2A and S2C) starting at day 7 after infection. In both
regions of the stomach, H. pylori in vivo density score was 2-
fold higher in Se than in the dominant Se
w phenotype from 4
to 10 months after inoculation (Figures 2B and S2B, P ,0.05).
Consistent with the higher infection load, secretors had
increased levels of gastritis compared to weak-secretors but
the difference was signiﬁcant only in the corpus (Figures 2D
and S2D). Interestingly, corpus gastritis scores increased
signiﬁcantly compared to pre-inoculation levels only in Se
monkeys but not in Se
w animals (Figure S2D). Finally, H. pylori
infection density and gastritis were strongly correlated (Table
1A).
Time-Dependent Suppression of Fucosylated Blood Group
Antigens during Infection
In all seven Se
w monkeys, both Le
b and Le
a antigens were
expressedinsurfaceepitheliumbeforeexperimentalinfection
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Author Summary
The common ABO blood group antigen system was described in the
early 20th century. In addition, it has been known for 60 years that
the majority of individuals also express the corresponding ABO
antigens (carbohydrate identity tags) in their saliva, tears, milk, and
mucus secretions in the digestive tract. To this date, however, the
biological function of the ABO blood group antigens has remained
an enigma. Here, we show that the great majority of Rhesus
monkeys are of blood group B and weak-secretors, i.e., are similar to
the human populations in South Asia from where these monkeys
originate. This observation suggests that an evolutionary adaptation
in digestive tract mucosal carbohydrate patterns to local environ-
mental selection has occurred. In addition, we demonstrate that
long-term infection by the ‘‘peptic ulcer bacterium’’ Helicobacter
pylori induces mucosal carbohydrate patterns that change according
to the individual secretor phenotype. The common weak-secretor
monkeys were apparently ‘‘protected,’’ as they had stable
glycosylation, lower inflammation, and lower bacterial infection
load, whereas the less common secretor animals had increased
levels of inflammation-associated mucosal carbohydrate patterns
and a transient decrease in the ABO blood group system type of
carbohydrates. These novel observations suggest that the individual
ABO blood group and secretor phenotype are part of human and
non-human primate innate immunity against infectious disease.(Figure 3A). At 1–4 weeks after inoculation, Le
b (Figure 3B)
and/or Le
a expression (data not shown) transiently decreased
in 5/7 monkeys. However, by 2–4 months, expression of Le
b/
Le
a returned to pre-inoculation levels or higher (Figure 3C).
Similarly, the fucosylated Lewis y (Le
y) antigen expressed in
the gastric glands of both Se and Se
w non-infected animals
initially decreased in response to inoculation, and then
returned to baseline in 8/10 monkeys (data not shown). Thus,
H. pylori infection causes general suppression of fucosylation
in the gastric mucosa, as reﬂected by the alterations in the
different Le
a,L e
b, and Le
y antigens (this series of fucosylated
Lewis antigens are described in Figure 1A).
Figure 1. Fucosylated and Sialylated Blood Group (bg) Antigens and Associated Secretor Phenotypes
(A) The a1.2-fucosylated (in red) H and Le
b antigens define bg O. Bg A and B antigens present additional GalNAc or Gal residues (blue), respectively. Le
y
and Le
b are both difucosylated. SLe
a and sLe
x are sialylated Lewis antigens (in pink).
(B) Synthesis pathways for bg antigens with corresponding Se phenotypes: Le
a is found in Se
0 individuals, whereas Se
w individuals carry a mix of
mucosal Le
a and Le
b.L e
a is formed when the Se-transferase is inactive or weak, because Le
a is a ‘‘dead-end’’ and is not extended further. During
inflammation and infection, sialyl-transferases are expressed and carbohydrate core chains become sialylated in competition with Se-fucosyltransferase.
(C) The presence of ABH and Le
a antigens in salivary, milk, and GI tract secretions identifies individuals of Se, Se
0,o rS e
w phenotype.
(D) In Se
w subjects, a1.2fucosylation is hampered by an enzymatically weak Se-transferase, whereas Se
0 individuals lack Se-transferase activity.
doi:10.1371/journal.ppat.0040002.g001
Table 1. Correlation Coefficients for Parameters That Were Found to be Statistically Significant (See ‘‘Statistics’’ in Materials and
Methods and in Protocol S1)
Variables Ro Rb Rw P
A. H. pylori density and gastritis score H. pylori density, A Gastritis score, A 0.61 0.72 0.56 ,0.001*
H. pylori density, C Gastritis score, C 0.56 0.82 0.38 ,0.001*
B. Sialylated Le antigens and H. pylori density/gastritis score Sialyl-Le
x,A .S H. pylori density, A 0.45 0.93 0.13 ,0.001*
Sialyl-Le
a,A .S H. pylori density, A 0.38 0.38 0.38 0.002*
Sialyl-Le
x, A. S Gastritis score, A 0.42 0.78 0.16 0.002*
Sialyl-Le
a, A. S Gastritis score, A 0.56 0.59 0.54 ,0.001*
Sialyl-Le
a, A. S Sialyl-Le
x, A. S 0.42 0.55 0.32 0.003
C. In vitro adherence of H. pylori strains In.v.ad. DbabA,A .S In.v.ad. DsabA,A .S  0.43  0.54  0.30 0.008
D. In vitro adherence of H. pylori strains and H. pylori density/gastritis score In.v.ad. DsabA,A .S H. pylori density, A  0.42  0.79 0.13 0.001*
In.v.ad. DbabA,A .S H. pylori density, A 0.51 0.64 0.44 ,0.001*
In.v.ad. DsabA, A. S Gastritis score, A  0.44  0.62  0.30 0.002*
In.v.ad. DbabA, A. S Gastritis score, A 0.48 0.70 0.31 0.001*
E. In vitro adherence of H. pylori strains and sialylated Le antigens In.v.ad. DsabA, A. S Sialyl-Le
x,A .S  0.54  0.79  0.24 ,0.001*
In.v.ad. DbabA, A. S Sialyl-Le
a, A. S 0.62 0.80 0.46 ,0.001*
A ¼Antrum, C ¼Corpus, S ¼surface/foveolar epithelium, DbabA ¼ babA1A2, DsabA ¼17875, and In.v.ad. ¼ in vitro adherence. * Denotes P-values that remain below 0.05 after Bonferroni
corrections.
doi:10.1371/journal.ppat.0040002.t001
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Response to Infection and Gastritis
The mean percentage of sialyl-Lewis a (sLe
a) and sialyl-
Lewis x (sLe
x) positive surface epithelial cells rapidly
increased in all monkeys with established H. pylori infection
(Figure 2E and 2F in antrum and in Figure S2E and S2F in
corpus). Sialyl expression is also illustrated in Figure 3D–3I.
Expression of sLe
a was stronger than that of sLe
x, and the
percentage of sLe
a positive cells rapidly increased 4-fold
within a week of inoculation. Thus, a majority of surface
epithelial cells (60%) express strong sLe
a at 2 months both in
antrum and corpus (Figures 2E and S2E). Similarly, expres-
sion of sLe
x was strongest at 2 months (Figure 2F). Expression
of sialylated antigens later decreased in seven monkeys
(Figures 2E and S2E and also illustrated in Figure 3F and
3I). Importantly, sLe
a and sLe
x expression in surface
epithelium of antrum correlated with both H. pylori density
and gastritis scores (see Table 1B).
Stable Expression of Gastric Type of Mucin Core Proteins
during Infection
The observed shifts in glycosylation were not due to pre-
dysplastic alterations of the gastric mucosa such as intestinal
metaplasia, because the spatial distribution of expression
patterns for the two common gastric mucins MUC5AC and
MUC6 (Figure S3) were unchanged during the 10-month
period of experimental infection, with no aberrant MUC2 or
atypical sulfo-mucins being detected (data not shown).
The In Vitro Adherence Patterns Revealed by BabA and
SabA Mutants Paralleled the Changes in Mucosal
Fucosylation and Sialylation Observed during Infection In
Vivo
The signiﬁcant correlation between H. pylori density and
gastritis and the similarity in time course (Figures 2A, 2C,
S2A, and S2C) suggest that the higher level of mucosal
inﬂammation is a consequence of the higher infection load.
Because of the exclusive binding properties of BabA (for
fucosylated antigens) and SabA (for sialylated antigens)
mediated binding properties [3,30], H. pylori mutants were
applied as lectin-like tools in an in vitro adherence assay to
functionally map detailed shifts speciﬁc for secretor-depend-
ent mucosal fucosylation and sialylation induced by H. pylori
infection and the associated inﬂammatory responses. The
DsabA (BabAþ) mutant bound fucosylated, secretor-depend-
ent ABH/Le
b antigens (but not the shorter Le
a or sialylated
antigens), whereas the DbabA (SabAþ) mutant bound inﬂam-
mation-associated sialylated (but not fucosylated) antigens
[2,5,31]. Representative adherence patterns of binding to
Rhesus monkey biopsies by the DsabA (BabAþ) and the DbabA
(SabAþ) mutants are shown in Figure S1. In histo-tissue
sections of gastric mucosa, the DsabA (BabAþ) mutant binds
to the foveolar epithelium cell surfaces and intra cellular
mucins and, in addition, to the secreted fucosylated mucus
layer. These binding tests demonstrate that BabA positive
bacteria co-localize with the MUC5AC mucin (compare
Figure S3A and S3C). By comparison, the DbabA (SabAþ)
mutant does not bind to the surface epithelium of non-
infected Rhesus monkey gastric mucosa, and SabA-mediated
binding instead colocalizes with the sialylated MUC6 mucin
expressed in the deeper located glandular region (compare
Figures S3B and S3D). However, when the mucosa during
infection has responded with expression of inﬂammation-
associated antigens, the DbabA (SabAþ) mutant binds to the
sialylated foveolar epithelium and mucus layer (illustrated in
Figure S1).
Importantly, in vivo, H. pylori binds to the intact apical cell
surfaces and secreted extracellular mucins in mucus, whereas
by the in vitro adherence assay and use of histo-tissue sections,
the H. pylori bacterial cells also bind to intracellular mucins
that have been exposed by histo sectioning of the mucosal
cells and tissue. Thus, the in vitro adherence method provides
an unique opportunity to investigate time-dependent
changes in secretor-dependent mucosal glycosylation that
occurs during H. pylori infection, i.e., using small pinch
biopsies collected at regular intervals during an extended
study period and without sacriﬁcing the animals. In the basal
state, the BabA-positive DsabA mutant adhered in vitro to the
non-inﬂamed, non-infected gastric mucosa of all ten Rhesus
monkeys (see Figures 4A and S3C), in accordance with the
Figure 2. Infection Density, Gastritis, and Mucosal Sialylation in Proximal
Stomach (Antrum), in Response to H. pylori Infection (Means 6 SEM)
The figure illustrates the time course of H. pylori infection density scores
in biopsies from the ten monkeys (A) and in three Se and seven Se
w
individuals following inoculation (B). Also illustrated is the time course of
gastritis scores in biopsies from the ten monkeys (C) and from the three
Se and seven Se
w individuals following inoculation (D). Finally, the mean
percentages of sLe
a positive (E) and sLe
x positive surface epithelium (F)
are shown in the ten monkeys following inoculation. * Illustrates
significant (P ,0.05) difference from pre-inoculation value and #
illustrates significant (P ,0.05) difference between Se and Se
w.
doi:10.1371/journal.ppat.0040002.g002
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monkeys. Following H. pylori inoculation, the dynamics of
glycosylation and inﬂammation were tightly correlated (see
Table 1), as revealed by the rapid and transient decrease in
BabA-mediated in vitro adherence that paralleled the ex-
pression patterns of fucosylated antigens (Compare Figure 4A
with Figure 3A–3C).
Expression of secretor-dependent mucosal fucosylation
involved in H. pylori adhesion remained strong and robust
throughout the 10-month observation period in Se
w subjects
compared to the rapid initial decrease in fucosylation in Se
individuals, as revealed by BabA-mediated in vitro adherence
to fucosylated bg antigens (Figure 4A). In addition, BabA-
mediated in vitro adherence to fucosylated mucosa was 1.7
times higher in Se
w than in Se monkeys (P ,0.001) and
inversely correlated with in vivo H. pylori density, gastritis,
and sLe
x expression (see Tables 1D and 1E, respectively).
Thus, Se
w with strong and robust expression of gastric
fucosylation have both lower H. pylori infection density and
less gastritis compared to Se individuals (Figures 4A, 2B, and
2D).
The strong fucosylation in Se
w monkeys, as revealed by the
robust BabA-mediated in vitro adherence, reﬂects the high
density of fucosylated mucins in the Se
w gastric mucosa.
Indeed, gastric mucins puriﬁed from healthy, non-infected
Rhesus monkey bind H. pylori primarily via fucosylated
structures (Figure S3E), similarly to human mucins binding
to H. pylori [4,14].
In contrast to BabA-mediated adherence, in vitro adher-
ence to sialylated glycoconjugates by the SabA positive
DbabA mutant was absent in the surface epithelium of
healthy, uninfected mucosa. However, SabA-mediated ad-
herence rapidly increased in response to inoculation, thus
demonstrating induction of mucosal sialylation. SabA-medi-
ated in vitro adherence to the surface epithelium correlated
with both in vivo H. pylori density and gastritis (Table 1D) and
with expression of the inﬂammation-associated sLe
x and
sLe
a antigens (Table 1E). Furthermore, SabA-mediated in
vitro adherence to sialylated glycoconjugates was 1.9-fold
higher in Se than in Se
w monkeys (Figure 4B). The rapid
induction of SabA-mediated binding to the sialylated surface
epithelium of the gastric mucosa (Figure 4B) demonstrates
that Se monkeys react with stronger inﬂammatory response
and higher recruitment of inﬂammatory cells, i.e., gastritis,
whereas the Se
w animals with low grade infection and
inﬂammation provides sparse mucosal sialylation and only
modest recruitment of inﬂammatory cells. Fucosylation and
sialylation levels follow opposite dynamics during the full
10-month observation period (fucosylation in Figures 4A
and 3A–3C; sialylation in Figures 4B and 3D–3I; Table 1C).
Thus, Se
w individuals are more robust in mucosal fucosyla-
tion and balanced in sialylation, which confers lower
inﬂammatory level, lower gastritis, and lower H. pylori
infection density as compared to Se individuals (Figures
2B, 2D, S2B, and S2D).
Discussion
The present study demonstrates that Se
w individuals have
robust mucosal fucosylation and lower mucosal inﬂammatory
and sialylation responses to experimental H. pylori infection.
Therefore, Se
w monkeys would be expected to better tolerate
Figure 3. Dynamic Reciprocity in Expression of Fucosylated and
Sialylated Antigens in Gastric Mucosa during H. pylori Infection
Le
b expression in monkey 8PZ at pre-inoculation (A), 1 week post-
inoculation (B), and 2 months post inoculation (C). Thus, gastric mucosal
fucosylation was initially strong (A), decreased from 1 to 4 weeks post-
inoculation (B), returned to basal level at 2 months (C), and stayed at
basal level until 10 months (not shown). The figure also illustrates the
expression of sialyl-Le
a (D, E, and F) and sialyl-Le
x (G, H, and I) in monkey
8PZ at pre-inoculation (D and G), 2 months (E and H), and 10 months
post-inoculation (F and I). Thus, gastric mucosal sialylation increased
during early infection (not shown), peaked at 2 months (E and H), and
returned to pre-inoculation levels at 10 months post-inoculation (F and I).
doi:10.1371/journal.ppat.0040002.g003
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high incidence of this type of infections. Such a selection for
speciﬁc blood group phenotypes is strongly suggested by our
observation that all 41 macaques included in the study
express blood group B antigens, especially since the blood
group B is the least common worldwide of the ABO
phenotypes. Interestingly, the ancestors of most macaques
used in the present study originated from Northern India,
which is the region with highest worldwide prevalence of bg B
phenotype in humans [32,33]. The recent Rhesus macaque
genome annotation revealed that the Indian and Chinese
groups diverged some 160,000 years ago [34]. Interestingly, all
the ABO blood groups are represented among macaques that
moved to Southeast Asia/Thailand [35], a region in which bg B
is lower in humans [32]. The human and macaque paralleled
demographic selection for high prevalence of Se
w and bg B
phenotype may result from selection by endemic infectious
disease [36] as the two species often suffer from the same
infectious diseases. Of particular relevance for the Indian
subcontinent, bg B individuals are less likely to become
infected by Vibrio cholera [37]. In addition, phylogenetic
analysis suggests that bg B arose several times and independ-
ently from bg A, indicating that the genes of these blood
group transferases are prone to convergent evolution [38].
The ABO blood groups were discovered over a century ago
[39], chemically described 50 year ago [40,41], and cloned
almost 20 years ago [42]. Similarly, the secretor system was
described 60 years ago [43], blood group antigens were
characterized from human intestine over 30 years ago [44]
and the Se transferase was cloned in 1995 [13], but the
biological and functional role of the ABO system has
remained an enigma [45]. Here, we show that secretor
phenotype determines the dynamics of mucosal glycosylation
in response to H. pylori infection and conditions the nature of
the host response. Thus, H. pylori infection is associated with
an increase in sialylated mucosal antigens and a concurrent
decrease in fucosylated mucosal antigens. The loss of
fucosylation during acute H. pylori infection is probably a
consequence of the fast induction in expression of inﬂam-
mation-associated sialyl-transferases and the resulting com-
petition for carbohydrate chains by glycosyl (sialyl and
fucosyl) transferases (Figure 1B). Competition between
fucosyl- and sialyl-transferases for the same carbohydrate
core chains was demonstrated by competition experiments
where di-saccharides suppressed both sialylation and for-
mation of selectin (endothelial cell adhesion) ligands on
cancer cells [46]. The present series of results also reveals that,
in contrast to Se monkeys, Se
w individuals maintain strong
and robust expression of fucosylated mucosal ABH antigens
during H. pylori infection (Figure 4A). Interestingly, intestinal
mucosal glycosylation also becomes fucosylated in response
to establishment of conventional bacterial ﬂora in gnoto-
biotic mice [47].
The combined results suggest that mucosal fucosylation
could be a mixed blessing for H. pylori. Indeed, large mucin
molecules with fucosylated high-afﬁnity binding sites for
BabA could be exploited by H. pylori as in vivo binding sites,
but they may also act as scouts of the host glycan innate
immunity system. Thus, the mucosal fucosylation represents a
protective scavenger factor that reduces infection density,
especially since H. pylori infection also increases gastric mucus
secretion [48]. The present demonstration that mucosal
fucosylation in response to H. pylori infection reduces
bacterial density and associated inﬂammation and, in
particular, impacts on infection in Se
w monkeys due to
stronger mucosal fucosylation phenotype, strongly suggests
that ABH secretor-dependent mucosal glycosylation modu-
lates innate immunity responses and may contribute to
variable risk of gastric disease.
Materials and Methods
Experimental animals. The experiments were conducted according
to the ‘‘Guide for the Care and Use of Laboratory Animals’’ [49]. All
procedures involving animals were reviewed and approved by the
USUHS animal care and use committee. The ancestors of 37 animals
had been captured in India, while four were of mixed Chinese and
Indian origin. The localization of Lewis antigens in these monkeys
before H. pylori inoculation has been investigated [15]. H. pylori and H.
heilmannii infection was eradicated in all monkeys 6 months before
inoculation [29]. The ten male monkeys that were inoculated all
originated from India and were 4–13 years old (mean 7.1). F754,
86D02, T4C, 8V5, F436, 82A49, and 8PZ animals were Se
w, and 86D06,
E6C, and 85D08 were Se.
Inoculation strains and cultures. Seven low-pass H. pylori strains
were cultured, characterized (ﬁve were CagAþ and two were CagA-)
(see Text S1), and inoculated to monkeys as reported [29]. Their
binding properties were analyzed by RIA [31]: J170, J254, J166, and
J258 bound both sLe
x and Le
b, J282 bound Le
b, and J178 bound sLe
x.
Immunohistochemistry. Genta-stained sections were used to
Figure 4. Time Course of Gastric Mucosal Fucosylation and Sialylation
following Inoculation of H. pylori to Rhesus Monkeys as Determined by
the In Vitro Adherence Assay
The figure illustrates that inoculation of H. pylori induces a strong, time-
dependent, increase in mucosal fucosylation and a concurrent suppres-
sion of inflammation-associated sialylation in Se monkeys (u), whereas
changes are milder in individuals of Se
w phenotype (“). The changes in
the glycosylation pattern were followed by use of in vitro adherence
analyses and fluorescent H. pylori bacterial cells as glycosylation-specific
lectin tools. Because the H. pylori DsabA (BabAþ) and DbabA (SabAþ)
mutants bind primarily to fucosylated and sialylated structures,
respectively, the time-dependent changes measured in terms of in vitro
adherence reflect parallel changes in surface epithelium fucosylation and
sialylation. In vitro adherence mediated by the BabA adhesin (in Figure
S1) identifies the mucosal expression patterns of secretor-dependent
fucosylation of ABH and Le
b antigens (A), whereas adherence mediated
by the SabA adhesin reveals mucosal sialylation (B). Importantly, only in
vitro adherence to surface epithelium is shown, because it is fucosylated
by the Se-transferase. From each of 120 biopsies, ten gastric pit regions
were acquired for digital analysis (i.e., a total of 1,200 mucosal zones
were analyzed) [31]. # Illustrates significant (P ,0.05) differences
between Se and Se
w subjects at the corresponding times.
doi:10.1371/journal.ppat.0040002.g004
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ABO Secretor Status Protects against Infectiondetermine H. pylori density scores and the Sydney system was used to
determine gastritis scores [29]. Sulfo-mucins were detected with high-
iron diamine stain [17]. Immunohistochemistry was performed as
described [15] (see Text S1). For quantitative histochemistry, tissue
sections were stained simultaneously. Non-sialylated carbohydrate
structures were quantiﬁed by visual estimation of intensity, whereas a
program by J. Czege, USUHS, was used for sialylated antigens. The
surface/foveolar epithelium, lamina propria and glands were sepa-
rately outlined and the percentage area stained was average from
three ﬁelds of view.
H. pylori adherence in vitro. The 17875/Le
b-mutant was referred to
as the DsabA (BabA
þ) mutant or ‘‘BabA-positive mutant’’, and the
isogenic 17875babA1::kan babA2::cam deletion mutant was referred to
as DbabA (SabA
þ) mutant or ‘‘SabA-positive-mutant [2,5]. In vitro
adherence was digitally quantiﬁed in a total of 1,200 mucosal zones
(120 biopsies, ten pits/biopsy) [31] (see Text S1).
Statistics. Data are reported as means 6 SEM. Changes over time
within animals were compared with a mixed-effects ANOVA model
corresponding to a repeated-measures ANOVA model with time as a
within-subject factor and secretor status as a between-subjects factor.
Dunnett’s post-hoc test was used to compare the average at each time
point to the average before inoculation. For each pair of variables,
three correlation coefﬁcients were calculated by ANOVA with
random effects (see Protocol S1/Statistics).
Supporting Information
Figure S1. BabA Adhesin-Mediated Binding of H. pylori to Fucosylated
ABO/Le
b Blood Group Antigens and SabA Adhesin-Mediated Binding
of H. pylori to Sialylated and Inﬂammation-Associated Antigens in
Primate Gastric Mucosa
Found at doi:10.1371/journal.ppat.0040002.sg001 (3.9 MB DOC).
Figure S2. Infection Density, Gastritis and Mucosal Sialylation in the
Proximal Stomach in Response to H. pylori Infection
Found at doi:10.1371/journal.ppat.0040002.sg002 (1.0 MB DOC).
Figure S3. Rhesus Monkey Gastric Mucins
Found at doi:10.1371/journal.ppat.0040002.sg003 (550 KB DOC).
Protocol S1. Supporting Protocols
1. Reagents
2. H. pylori culture
3. Mucin isolation and analyses of blood group glycosylation
4. H. pylori binding to mucins in ELISA
5. Statistics
Found at doi:10.1371/journal.ppat.0040002.sd001 (34 KB DOC).
Table S1. Individual Values of Gastritis Scores, H. pylori In Vivo
Density, and Antral and Body sLe
x and sLe
a Staining for Antrum and
Body, and Antral Mucosal Fucosylation and Sialylation Patterns
Revealed by In Vitro Adherence Mediated by BabA and SabA,
Respectively
Found at doi:10.1371/journal.ppat.0040002.st001 (266 KB DOC).
Text S1. Supporting References
Found at doi:10.1371/journal.ppat.0040002.sd002 (46 KB DOC).
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